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Abstract
Background: Little is known about whether growing awareness of the financial toxicity of 
cancer diagnosis and treatment has increased clinician engagement or changed current patients’ 
needs.
Methods: We surveyed patients with early-stage breast cancer, identified through population-
based sampling from two SEER regions, and their physicians. We describe responses from 73% of 
surgeons (n=370), 61% of medical oncologists (n=306), 67% of radiation oncologists (n=169), and 
68% of patients (n=2502).
Results: Half (50.9%) of responding medical oncologists reported that someone in their practice 
often or always discusses financial burden with patients, as did 15.6% of surgeons and 43.2% of 
radiation oncologists. Patients indicated that financial toxicity remains common: 21.5% of whites 
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and 22.5% of Asians had to cut down spending on food, as did 45.2% of blacks and 35.8% of 
Latinas. Many patients desired to talk to providers about the financial impact of cancer: 15.2% of 
whites, 31.1% of blacks, 30.3% of Latinas, and 25.4% of Asians. Unmet patient needs for 
engagement with doctors about financial concerns were common. Of 945 women who worried 
about finances, 679 (72.8%) indicated that doctors and their staff did not help. Of 523 women who 
desired to talk to providers about the impact of breast cancer on employment or finances, 283 
(55.4%) reported no relevant discussion.
Conclusion: Many patients report inadequate clinician engagement in management of financial 
toxicity, even though many providers believe that they make services available. Clinician 
assessment and communication regarding financial toxicity must improve; cure at the cost of 
financial ruin is unacceptable.
Precis:
Unmet patient needs for engagement with doctors about financial concerns were common in this 
survey of breast cancer patients, with 73% of 945 women who worried about finances indicating 
that cancer doctors and their staff did not help. Even physicians who perceive that they are 
routinely offering necessary services may fail to meet patient needs.
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Introduction
Financial toxicity is increasingly recognized as a serious concern for patients with cancer,1, 2 
even if they have health insurance.3, 4 Patients with cancer can experience disruptions in 
employment that affect income5–11 as well as substantial out-of-pocket costs associated with 
their care, and studies have shown higher rates of bankruptcy filing among patients with 
cancer.12, 13 Financial burden has also been associated with overall distress, lower health-
related quality of life,14, 15 and lower satisfaction with cancer care.16
Little is known about whether growing attention to these issues in the medical literature and 
popular press has motivated physicians to more routinely embrace practices that address and 
attempt to mitigate financial toxicity. Furthermore, we know virtually nothing about the level 
of cancer physicians’ engagement with patients about financial toxicity and patients’ 
perceptions about unmet need.
To address these issues, we sought to document the relevant self-reported practices of 
surgeons, medical oncologists, and radiation oncologists engaged in delivering care to a 
cohort of patients with breast cancer, who were identified through population-based 
sampling from two large SEER catchment areas, along with the experiences of their patients. 
Specifically, we investigated the frequency of these specialists’ reporting that someone in 
their practice discusses the financial burden of cancer treatments with patients, their 
awareness of the out-of-pocket costs of the tests and treatments they recommend, how 
important they perceived it to be to save money for their patients. We further sought to 
evaluate the financial toxicity experiences of the patients in this modern population-based 
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cohort, by race and ethnicity, including perceptions of the extent to which their oncologists, 
staff, and other professionals had assisted in addressing the impact of breast cancer on 
employment or finances, the characteristics of those who express a desire for clinician 
engagement, and the number who continue to have unmet needs.
Methods
Patient Sample and Data Collection
The iCanCare study identified women aged 20–79 years diagnosed with early-stage breast 
cancer between January 2013 and September 2015, as reported to the Surveillance, 
Epidemiology and End Results (SEER) registries of Georgia and Los Angeles County, using 
rapid case ascertainment methods.17 Exclusion criteria included prior breast cancer, stage 
III-IV disease, or tumors >5cm
After IRB approval, we surveyed patients (median time to survey response 7.7 months) and 
merged responses with SEER data. We provided a $20 incentive and used a modified 
Dillman approach to improve response rate. 18 Of 3672 patients surveyed, 2502 (68%) 
responded.
Physician Sample and Data Collection
Attending surgeons and oncologists were identified primarily through patient report, as well 
as from information in the SEER database. Most patients identified an attending surgeon 
(94%) and medical oncologist (81%); 53% identified a radiation oncologist (53%). From the 
510 identified surgeons, 504 identified medical oncologists, and 251 identified radiation 
oncologists, we obtained survey responses from 370 surgeons (73%), 306 medical 
oncologists (61%), and 169 radiation oncologists (67%).
Measures
Questionnaires were developed using an iterative design process.19 We employed standard 
techniques to assess content validity. This included review by survey design experts and 
cognitive interviewing20 with patients and clinicians outside our target sample. Several 
domains relating to finances were evaluated.
Physician-reported communication and attitudes about financial issues: Three 
physician survey measures related to communication and attitudes about patient financial 
challenges: 1) “How often does someone in your primary practice discuss the financial 
burden of cancer treatments with your patients?” (never, rarely, sometimes, often, and 
always); 2) “How aware are you of the out-of-pocket costs of the tests and treatments you 
recommend?” (not at all, a little, somewhat, quite, or very aware); 3) “When it comes to 
breast cancer treatment, how important to you is it to save your patients money?” (not at all, 
a little, somewhat, quite, or extremely).
Patient report of financial toxicity: Patient survey measures related to financial burdens 
of the disease and treatment included several independent aspects of this complex construct: 
1) lost income since breast cancer diagnosis, 2) out-of-pocket medical expenses related to 
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breast cancer (including co-payments, hospital bills, and medication costs), and 3) out-of-
pocket non-medical expenses over and above the normal budget related to breast cancer 
(e.g., supplies like wigs, bras, or bandages; travel; child/elder care; and complementary or 
alternative medicine). These were categorized as 0, $1-$500, $501-$2000, $2001-$5000, 
$5001-$10,000, and >$10,000. In addition, we calculated the proportion of respondents for 
whom ≥10% of household income was in each of these categories (lost income and out of 
pocket expenses).
We also asked whether respondents currently had debt (including unpaid bills, credit card 
balance, bank loans, or borrowing money from family/friends) from breast cancer treatment 
(yes or no). We inquired whether, due to the financial impact of breast cancer, respondents 
had to use savings, could not make payments on credit cards or other bills, cut down on 
spending for food, had utilities turned off because of unpaid bills, or had to move out of their 
house or apartment because they could not afford to stay there (yes or no).
We evaluated whether patients perceived themselves to be worse off since breast cancer 
diagnosis in terms of employment status and separately in terms of financial status, and we 
reported the proportion of these who attributed this at least partly to breast cancer and 
treatment. We further assessed how much patients worried about current or future financial 
problems as a result of breast cancer and treatments. Response options for these items were 
not at all, a little, somewhat, quite a bit, or a lot, and were dichotomized as at least somewhat 
versus not for analysis.
Patient report of desire for and experiences with clinician engagement: We 
inquired how much patients wanted to talk to their health care providers about the impact of 
having breast cancer on their employment or finances. Response options for these items 
were not at all, a little, somewhat, quite a bit, or a lot, and were dichotomized as at least 
somewhat versus less (i.e. a little or not at all) for analysis. We also assessed patient report 
of engagement with clinicians about financial impact of the disease and treatment. Patients 
were asked, “During your breast cancer experience, how much did you discuss the impact of 
having breast cancer on your employment or finances with each of the following people?” 
Separate items specified “cancer doctors,” “social worker or other professional,” and 
“primary care doctor.” We further inquired: “How much did your cancer doctors and their 
staff help you in dealing with the impact of having breast cancer on your employment or 
finances?” Response options for these items were not at all, a little, somewhat, quite a bit, or 
a lot.
Patients’ unmet needs related to financial toxicity concerns: Finally, we 
developed two measures of unmet need. First, we defined unmet need for communication as 
having expressed a desire to talk with health care providers about the impact of breast cancer 
on employment or finances at least somewhat, but having failed to discuss this at least 
somewhat. Second, we defined unmet need for help with finances as expressing worry about 
financial problems at least somewhat but indicating that cancer doctors and their staff did not 
help at least somewhat.
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Covariates: Surveys also ascertained age, race/ethnicity (white, black, Latina, Asian), 
education (high school or less, some college, ≥college graduate), household income (<$20K, 
$20 to <$40K, $40K to <$90K, ≥$90K), employment status before diagnosis (full-time, 
part-time, or not working before diagnosis), insurance status (none, Medicaid, Medicare, 
private), marital status (married/partnered versus not), and site (Los Angeles, Georgia). 
Physician characteristics included specialty (medical oncology, surgery, or radiation 
oncology), annual volume of new breast cancer patients, whether in a teaching practice, and 
years of experience.
Statistical Analysis
Results from the physician survey were weighted to account for differential nonresponse.21 
Results are presented as unweighted number values, with weighted percentages to describe 
responses regarding physician-reported communication and attitudes.
Results from the patient survey were weighted to account for sampling design and 
differential nonresponse. To correct for potential bias due to missing data in the patient 
surveys, values for missing items were imputed using multiple imputation. Results are 
presented as unweighted, non-imputed number values, with weighted imputed percentages. 
For the patient-level analyses, we described patient reports of financial toxicity, patient 
report of clinician engagement, and unmet needs by race/ethnicity. We also constructed a 
multiple variable regression model to evaluate the correlates of desire for discussion about 
finances, using theoretically prespecified independent variables: age, race/ethnicity, 
education, household income, employment status before diagnosis, insurance status, marital 
status, and site.
Analyses were conducted using SAS statistical software, version 9.4 (SAS Institute Inc).
Results
Physician Surveys
Of the responding surgeons, 92 (21.3%) were female; 98 (31.6%) of the responding medical 
oncologists were female; and 46 (26.8%) of the responding radiation oncologists were 
female. The mean numbers of years in practice were 21.6 (SE = 0.6) for surgeons, 15.7 (SE 
= 0.7) for medical oncologists, and 17.2 (SE = 0.9) for radiation oncologists. Of the 
responding surgeons, 110 (28.2%) were in teaching practices, as were 60 (21.0%) of the 
medical oncologists and 46 (27.1%) of the radiation oncologists. Of the responding 
surgeons, 109 (24.8%) saw >50 new breast cancer patients in the past year, as did 109 
medical oncologists (34.4%) and 93 (53.5%) radiation oncologists (53.5%) [Supplementary 
Table 1].
As shown in Table 1, many physicians reported engagement and concern regarding costs and 
financial burden. Of responding medical oncologists, 50.9% reported that someone in their 
practice often or always discusses the financial burden of cancer with patients,
As did 15.6% of surgeons and 43.2% of radiation oncologists. Of the medical oncologists, 
40.0% believed themselves to be quite or very aware of the out-of-pocket costs of tests and 
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treatments they recommend, as did 27.3% of surgeons and 34.3% of radiation oncologists. 
Finally, 57.0% of medical oncologists viewed it to be quite or extremely important to save 
their patients money, as did 35.3% of surgeons and 55.8% of radiation oncologists.
Patient Surveys
Table 2 shows the diversity of the patient sample, which included 463 blacks, 516 Latinas, 
and 240 Asians. About a quarter (785, 28.9%) had a high school education or less, and 760 
(37.2%) had household income below $40,000 per annum.
As shown in Table 3, all measures of patient-reported financial toxicity varied significantly 
by race/ethnicity (p<0.01). Many women reported debt from treatment, including 27.1% of 
whites, 58.9% of blacks, 33.5% of Latinas, and 28.8% of Asians. Many patients also had 
substantial lost income and out-of-pocket expenses that they attributed to breast cancer. 
Overall, 14% of patients reported lost income that was ≥10% of their household income, 
17% of patients reported spending ≥10% of household income on out-of-pocket medical 
expenses, and 7% of patients reported spending ≥10% of household income on out-of-
pocket nonmedical expenses (not shown in table).
Privations attributed to breast cancer varied by race/ethnicity. Few whites (1.4%) or Asians 
(1.0%) lost their home, but 4.7% of blacks and 6.0% of Latinas did. Similarly, although only 
1.7% of whites and 0.5% of Asians had utilities turned off for unpaid bills, 5.9% of blacks 
and 3.2% of Latinas did. One in five whites (21.5%) and Asians (22.5%) cut down spending 
on food, as did nearly half of blacks (45.2%), and over a third of Latinas (35.8%). Many 
women were at least somewhat worried about finances as a result of breast cancer or its 
treatment: 31.9% of whites, 48.9% of blacks, 49.7% of Latinas, and 35.2% of Asians.
A substantial minority expressed desiring, at least somewhat, to talk to healthcare providers 
about the impact of breast cancer on their employment or finances, and this was more 
common among non-whites: 15.2% of whites, 31.1% of blacks, 30.3% of Latinas, and 
25.4% of Asians. On multivariable analysis, as shown in Figure 1 (and detailed in 
Supplementary Table 2), the following characteristics were independently associated with 
desire for a discussion with healthcare providers about the impact of breast cancer on their 
employment or finances: younger age, non-white race, lower income, being employed (full 
time or part time), receiving chemotherapy, and Georgia residency.
Unmet patient needs for engagement with doctors about financial concerns were common. 
Of the 945 women who expressed worrying at least somewhat, 679 (72.8%) indicated that 
cancer doctors and their staff did not help at least somewhat. Of the 523 women who 
expressed a desire to talk to healthcare providers about the impact of breast cancer on 
employment or finances, 283 (55.4%) reported that they had not had a relevant discussion 
with their cancer doctors, primary care providers, social workers, or other professionals. 
Figure 2 shows, by race/ethnicity, the proportion of patients with unmet needs for 
communication among those with desire to discuss and the proportion with unmet needs for 
assistance among those with worry.
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Discussion:
In this recent, population-based sample of breast cancer patients diagnosed in two large 
SEER catchment areas of the United States and surveyed less than one year after diagnosis, 
financial toxicity and desire for clinician engagement were already substantial and varied by 
race/ethnicity, with vulnerable groups including the young and those who receive 
chemotherapy. Although many physicians, particularly medical oncologists, report 
attempting within their practices to help manage financial issues with their patients, marked 
unmet need remains. Over two-thirds of patients who were worried about finances as a result 
of breast cancer or its treatment reported that their cancer doctors and staff did not help 
substantially. Moreover, over half of those who expressed a desire to discuss the impact of 
breast cancer on employment or finances reported that they had not had such a discussion.
The privations observed in this study are sobering and consistent with studies prior to the 
widespread awareness of the potential for financial toxicity after cancer diagnosis and 
treatment. In a similar population-based sample of patients with breast cancer diagnosed a 
decade ago, our own group demonstrated concerning rates of serious privations during 
survivorship, such as economically motivated treatment non-adherence or loss of one’s 
home.22 However, with growing awareness of financial toxicity and attempts to mitigate it 
by providers, we had hoped that these experiences would be rare in a more modern sample 
surveyed relatively soon after diagnosis. Disappointingly, we observed that one in twenty 
black or Latina patients had already lost their home due to breast cancer diagnosis or 
treatment. Nearly one in five whites and Asians had to cut down spending on food, and 
nearly half of blacks and over a third of Latinas reported this privation.
This study also offers important insights about the extent to which the medical community 
has begun to attempt to address these major concerns. An intriguing analyses of videotaped 
interactions between African American patients and oncologists at two urban cancer 
hospitals suggested that cost discussions occur in 45% of clinical interactions.23 The current 
study builds on these findings and suggests that certain providers (medical oncologists) are 
more likely to have someone in their practice who routinely addresses these issues. 
Unfortunately, unmet needs for discussion persist, as does unresolved worry. The proportion 
of patients who perceive meaningful clinician engagement is low, with far fewer than a 
quarter of respondents reporting more than a little discussion of these issues—and this is 
strikingly lower than the proportion of providers (over half of medical oncologists) who 
perceive routinely making services available.
Given these findings, it is clear that thoughtfully designed, prospective interventions are 
necessary to address the remarkably common experiences of financial burden that patients 
report even in the modern era. These interventions might include training for physicians and 
their staff regarding how to have effective conversations in this context, in ways that are 
sensitive to cultural differences and needs. Other promising approaches might include the 
use of advanced technology to engage patients in interactive exercises that elicit their 
financial concerns and experiences and alert providers to their needs. Scholars have already 
developed useful tools for the rigorous evaluation of financial experiences that are ideally 
suited as endpoints in studies that seek improvement of financial burden.24
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Although this study has considerable strengths, including its large, population-based sample, 
its evaluation of a number of both objective and subjective measures of financial burden, and 
its inclusion of both physicians and the patients they serve, it also has limitations. All data 
regarding finances derive from self-report, but measures were developed in accordance with 
principles of rigorous survey design and demonstrate strong face and internal validity. Not 
all sampled patients or physicians responded to our surveys, and this may introduce bias, but 
the rates of response were substantial and considerably higher than in most other patient and 
physician studies. Not all patients saw all types of providers (particularly radiation 
oncology), but the vast majority did see both surgeons and medical oncologists. We were 
unable to conduct linked multilevel analyses due to the biases that would be introduced by 
the different provider mix of each patient. Finally, the study was based in two regions; 
although these are large catchment areas, experiences in other regions of the United States 
might differ, and the results should not be extrapolated to other countries, where costs, 
healthcare systems and coverage of care, policies, and culture differ markedly in ways that 
likely affect financial experiences and outcomes.
Implications:
For many women, a breast cancer diagnosis no longer causes the physical devastation that it 
once did. Advances in early detection and less extensive surgery, radiotherapy, and systemic 
therapy have transformed a disease that once left patients disfigured at best—and at worst 
took their lives after terrible morbidity. Although progress in breast cancer treatment is 
laudable, this study demonstrates that we have gone only part of the way to our goal. Efforts 
must now turn to confront the financial devastation that many patients face, particularly as 
they progress into survivorship. The first steps for clinical practice and policy are clear: all 
physicians must assess patients for financial toxicity and learn how to communicate 
effectively about it. To cure a patient’s disease at the cost of financial ruin falls short of the 
physician’s duty to serve – and failure to recognize and mitigate a patient’s financial distress 
is no longer acceptable.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1: Factors Associated with Need for Communication About the Financial Impact of 
Breast Cancer
Odds Ratios and 95% confidence intervals from a multivariable logistic regression.
Estimates are from a multiple variable regression model that evaluated the correlates of 
patients’ self-reported desire to talk to health care providers about the impact of having 
breast cancer on employment or finances (model more fully detailed in data supplement, 
online-only). From 2502 patients diagnosed with breast cancer in the iCanCare study.
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Figure 2: Unmet Need For Assistance and Communication Regarding Finances
* Percentage of patients who reported receiving little or no help from their doctors and staff 
in dealing with the financial impact of cancer, among those who expressed somewhat or 
greater worry about financial problems. P value from Pearson χ2 test.
** Percentage of patients who reported little or no discussion of the financial impact of 
cancer, among those who expressed somewhat or greater desire to talk with health care 
providers about financial issues.
*** P values from Pearson χ2 test.
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Table 1:
Self-reported physician practices, knowledge, and attitudes regarding financial toxicity
Surgeon* Medical oncologist* Radiation oncologist*
Frequency of discussing financial burden of cancer treatments with patients
 Never 63 (18.2%) 10 (3.5%) 5 (2.8%)
 Rarely 133 (36.9%) 40 (13.5%) 36 (23.0%)
 Sometimes 110 (29.2%) 94 (32.2%) 49 (30.0%)
 Often 54 (13.8%) 113 (40.3%) 48 (31.0%)
 Always 7 (1.8%) 33 (10.6%) 23 (13.2%)
Awareness of out-of-pocket costs of tests and treaments they recommend
 Not at all 41 (10.5%) 9 (3.1%) 7 (3.6%)
 A little 100 (26.5%) 50 (17.3%) 39 (23.3%)
 Somewhat 123 (35.7%) 111 (39.6%) 62 (38.8%)
 Quite 76 (19.0%) 89 (30.1%) 39 (26.1%)
 Very 26 (8.3%) 28 (9.9%) 15 (8.2%)
Importance of saving patients money
 Not at all 45 (13.3%) 3 (1.0%) 6 (3.5%)
 A little 68 (20.3%) 35 (11.8%) 15 (8.4%)
 Somewhat 115 (31.1%) 86 (30.2%) 53 (32.3%)
 Quite 121 (31.6%) 120 (41.3%) 63 (40.0%)
 Extremely 15 (3.7%) 45 (15.7%) 24 (15.8%)
*Unweighted n and weighted percentage
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Table 2:
Characteristics of responding patients
Number Weighted %
Age
<40 57 2.5
40–49 305 14.2
50–59 629 26.1
60–69 843 36.0
70+ 667 21.2
Missing 1
Race
White 1227 56.7
Black 463 17.5
Latina 516 14.9
Asian 240 10.9
Other/unknown/missing 56
Education
High school or less 785 28.9
Some college 720 30.2
College graduate or greater 922 40.9
Missing 75
Income
<$20K 382 18.8
$20K-<$40K 378 18.4
$40K-<$60K 329 16.0
$60K-<$90K 339 17.7
$90K or more 578 29.1
Don’t know or not reported 496
Employed before diagnosis
Full time 931 49.5
Part time 256 11.0
Not employed 1015 39.5
Missing 300
Insurance
None 110 5.3
Medicaid 242 10.9
Medicare 630 29.2
Private 1196 54.6
Missing 324
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Number Weighted %
Marital status
Not married or partnered 961 39.1
Married or partnered 1496 60.9
Missing 45
Site
Georgia 1261 49.0
Los Angeles 1241 51.0
Surgery
BCS 1566 65.9
Mastectomy 883 34.1
Missing 43
Chemotherapy
Not initiated by time of survey 1695 73.1
Yes 732 26.9
Missing 75
Radiation
Not initiated by time of survey 1158 46.3
Yes 1284 53.8
Missing 60
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Table 3:
Patient-reported financial toxicity and clinician engagement by race/ethnicity
Characteristic Weighted %*
White (n=1227) Black (n=463) Latina (n=516) Asian (n=240)
Lost income
0 73.8 62.9 58.4 59.6
$1-$500 3.5 3.0 5.1 2.9
$501-$2000 6.1 9.6 9.8 9.3
$2001-$5000 5.4 10.9 10.2 10.8
$5001-$10,000 5.6 7.8 7.7 8.6
>$10,000 5.6 5.8 8.9 8.8
Out of pocket medical expenses
0 11.7 12.7 28.9 15.0
$1-$500 23.6 28.1 27.0 28.9
$501-$2000 19.4 26.3 18.3 21.7
$2001-$5000 23.9 17.8 15.7 18.1
$5001-$10,000 16.3 12.0 7.5 12.3
>$10,000 5.1 3.2 2.6 4.0
Out of pocket non-medical expenses
0 24.3 19.5 29.9 16.7
$1-$500 46.0 45.6 38.4 43.0
$501-$2000 19.1 21.7 21.2 23.1
$2001-$5000 7.6 8.9 7.4 10.3
$5001-$10,000 2.1 2.8 2.8 5.0
>$10,000 0.9 1.5 0.3 1.9
Current debt from treatment 27.1 58.9 33.5 28.8
Had to use savings 35.6 52.3 46.8 43.8
Could not make payments on bills 11.6 32.1 19.3 9.0
Cut down spending on food 21.5 45.2 35.8 22.5
Utilities turned off for unpaid bills 1.7 5.9 3.2 0.5
Lost home 1.4 4.7 6.0 1.0
Employment status worse off at least partly due to breast cancer 13.2 23.5 28.5 15.2
Financial status worse off at least partly due to breast cancer 37.3 54.7 48.8 34.8
Worry about finances
Characteristic Weighted %*
White (n=1227) Black (n=463) Latina (n=516) Asian (n=240)
Not at all 41.4 29.2 26.2 34.6
A little 26.7 21.9 24.1 30.2
Somewhat 15.2 18.0 21.2 14.4
Quite a Bit 9.7 17.0 15.2 8.1
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Characteristic Weighted %*
White (n=1227) Black (n=463) Latina (n=516) Asian (n=240)
A lot 7.0 13.9 13.3 12.7
Desire to talk to healthcare providers about impact of breast cancer 
on employment or finances
Not at all 72.2 55.7 55.7 57.1
A little 12.7 13.3 13.9 17.4
Somewhat 8.0 13.9 12.6 13.0
Quite a Bit 4.3 9.9 12.1 5.9
A lot 2.8 7.3 5.6 6.5
Discussed impact of breast cancer on employment or finances with 
cancer doctors
Not at all 75.0 66.6 66.7 66.6
A little 14.5 15.2 10.4 17.9
Somewhat 6.0 10.1 10.4 9.1
Quite a Bit 2.4 4.4 8.3 2.8
A lot 2.1 3.7 4.3 3.6
Discussed impact of breast cancer on employment or finances with 
social worker or other professional
Not at all 84.9 70.8 73.9 77.3
A little 7.4 9.6 8.6 7.9
Somewhat 3.6 9.0 7.0 6.7
Quite a Bit 2.5 7.1 6.4 3.8
A lot 1.7 3.6 4.1 4.4
Discussed impact of breast cancer on employment or finances with 
primary care doctor
Not at all 89.2 78.6 74.8 77.4
A little 5.3 9.4 7.2 12.0
Somewhat 3.2 6.9 7.2 6.0
Quite a Bit 1.1 2.2 5.5 1.9
A lot 1.1 2.9 5.4 2.7
All comparisons are significant (p<0.01) in Chi-square tests.
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